Antimicrobial efficacy testing showing zone of inhibition in certified laboratory conditions
Aerospace corrosion testing per MIL-STD-810 evaluating alloy and coating protection performanceWhat Is Preservative Effectiveness Testing?
Preservative Effectiveness Testing (PET) — also called the Antimicrobial Effectiveness Test (AET) or Challenge Test — evaluates whether the concentration of antimicrobial preservative agents in a formulation is sufficient to prevent the growth of, and reduce or eliminate, microorganisms introduced as contaminants during normal product use. It is a mandatory quality control and regulatory submission requirement for multi-dose pharmaceutical products, ophthalmic preparations, topical formulations, and cosmetics — industries in which repeated consumer or patient access to product containers during use creates contamination risk.
Why Preservative Testing Is Critical
Multi-dose eye drops, nasal sprays, injectable vials, topical creams, and cosmetic products are opened, used partially, and stored for days to weeks between uses. Without adequate preservative protection, each opening event introduces airborne bacteria and fungi — organisms capable of colonizing the product, causing spoilage, or causing serious infections (particularly in ophthalmic and injectable products, where contamination has led to permanent vision loss and septicemia).
Regulatory agencies — FDA (21 CFR), EMA (European Medicines Agency), and WHO — require documented evidence of preservative effectiveness as part of drug product specifications and stability programs.
USP 51 — Antimicrobial Effectiveness Testing
Test Organisms and Inoculation
USP 51 specifies a panel of five challenge organisms:
- Candida albicans (ATCC 10231) — yeast
- Aspergillus brasiliensis (ATCC 16404) — mold
- Escherichia coli (ATCC 8739) — Gram-negative bacterium
- Pseudomonas aeruginosa (ATCC 9027) — Gram-negative bacterium
- Staphylococcus aureus (ATCC 6538) — Gram-positive bacterium
Each organism is individually inoculated into the product at 10⁵–10⁶ CFU/mL, and surviving populations are enumerated at specified intervals (7, 14, 28 days for Category 1; 14 and 28 days for Category 3).
Acceptance Criteria by Product Category
- Category 1 (injections, ophthalmic): No increase from initial count at 14 days; no increase at 28 days for bacteria; no increase from 14-day count for yeasts/molds
- Category 2 (topical, non-sterile): Reduce bacteria by 2 log at day 14; no increase at day 28; no increase in yeasts/molds from initial count
- Category 3 (oral non-aqueous): No increase in bacteria or fungi from initial count throughout 28 days
EP 5.1.3 — European Pharmacopoeia Equivalent
EP 5.1.3 uses the same test organisms and incubation scheme but defines Criteria A and Criteria B with different log reduction requirements. Criteria A is preferred (more stringent); Criteria B is acceptable where Criteria A cannot be achieved without compromising product safety or efficacy.
Testing Considerations
Matrix Effects and Neutralization
Product matrices — surfactants, oils, antimicrobial APIs, and chelating agents — can inhibit test-organism growth or interfere with enumeration. Neutralization validation per USP 51 confirms that the enumeration media and neutralizer adequately inactivate the preservative at the sampling step, ensuring accurate viable-count recovery.
Preservative Stability Integration
PET is performed at defined stability time points — initial, 6-month, 12-month, and end-of-shelf-life — to confirm that preservative effectiveness is maintained throughout the product’s labelled shelf life, as preservative concentration may decrease due to degradation, absorption into container walls, or pH changes.
Conclusion
Preservative Effectiveness Testing is vital to ensuring that pharmaceutical and cosmetic products remain stable and free from microbial contamination. The validation of antimicrobial protection against standard challenge organisms, as well as compliance with USP/EP criteria, is significant for ensuring product stability and safety.
Why Choose Infinita Lab for Preservative Effectiveness Testing?
Infinita Lab addresses the most frustrating pain points in PET testing: complexity, coordination, and confidentiality. Our platform delivers USP 51, EP 5.1.3, and ISO 11930 compliant testing across an accredited nationwide lab network — fast, documented, and behind the scenes.
Looking for a trusted partner to achieve your research goals? Schedule a meeting with us, send us a request, or call us at (888) 878-3090. [Request a Quote]
Frequently Asked Questions
What is the difference between USP 51 and EP 5.1.3 for preservative effectiveness testing? Both use the same five test organisms and 28-day incubation with sampling at specified intervals. USP 51 defines acceptance by product category (1, 2, 3) based on route of administration. EP 5.1.3 defines Criteria A (preferred, more stringent) and Criteria B (acceptable alternative). Regulatory submission requirements specify which standard applies — FDA NDA/ANDA submissions follow USP 51; EMA submissions follow EP 5.1.3.
What preservatives are used in ophthalmic products? Benzalkonium chloride (0.004–0.02%) is most common. Alternatives include Polyquad, sodium perborate, Purite, and EDTA systems. Preservative-free unit-dose formats are increasing due to toxicity concerns with long-term use.
How does neutralizer validation work in USP 51? It ensures neutralizer supports microbial growth, eliminates preservative carry-over, and enables recovery. Includes growth control, neutralization effectiveness, and direct inoculation recovery to validate accurate preservative effectiveness testing results.
When is preservative effectiveness testing required? Required during formulation development, regulatory submissions, stability studies, and after changes in formulation, packaging, or process. Also conducted periodically for ongoing stability monitoring of approved pharmaceutical products.
What happens if a product fails USP 51? Failure indicates insufficient preservation. Reformulation, higher preservative concentration, or packaging changes are needed. Approval cannot proceed until effectiveness meets criteria, ensuring adequate microbial protection during product shelf life and use.
